175 related articles for article (PubMed ID: 30683264)
41. The cost-utility of integrated cervical cancer prevention strategies in the Ontario setting - Can we do better?
Sander B; Wong WW; Yeung MW; Ormanidhi O; Atkin K; Murphy J; Krahn M; Deeks SL
Vaccine; 2016 Apr; 34(16):1936-44. PubMed ID: 26892739
[TBL] [Abstract][Full Text] [Related]
42. HPV vaccination and colposcopy workload of screening programmes.
Zorzi M; Giorgi-Rossi P
Vaccine; 2008 Dec; 26(52):6743-4. PubMed ID: 18950669
[No Abstract] [Full Text] [Related]
43. Comparative cost-effectiveness of HPV vaccines in the prevention of cervical cancer in Malaysia.
Ezat SW; Aljunid S
Asian Pac J Cancer Prev; 2010; 11(4):943-51. PubMed ID: 21133606
[TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus vaccination and Pap testing profile in Manitoba, Canada.
Kliewer EV; Mahmud SM; Demers AA; Lambert P
Vaccine; 2013 Dec; 32(1):33-8. PubMed ID: 24211170
[TBL] [Abstract][Full Text] [Related]
45. HPV vaccination: effects on cervical screening.
Kothari A
Nurs Times; 2014 Jun 11-17; 110(24):19-21. PubMed ID: 25007499
[TBL] [Abstract][Full Text] [Related]
46. Optimizing secondary prevention of cervical cancer: Recent advances and future challenges.
Ogilvie G; Nakisige C; Huh WK; Mehrotra R; Franco EL; Jeronimo J
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():15-19. PubMed ID: 28691338
[TBL] [Abstract][Full Text] [Related]
47. [Counseling protocol for early cancer detection at the Women's Health Center in Ruma].
Nedić B; Ravić J; Loncar S; Cuk D
Med Pregl; 1999; 52(3-5):162-4. PubMed ID: 10518403
[TBL] [Abstract][Full Text] [Related]
48. Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.
Chen MK; Hung HF; Duffy S; Yen AM; Chen HH
J Eval Clin Pract; 2011 Dec; 17(6):1050-8. PubMed ID: 21679279
[TBL] [Abstract][Full Text] [Related]
49. The Annual Gynecologic Examination Updated for the 21st Century.
Cappiello J; Levi A
Nurs Womens Health; 2016; 20(3):315-9. PubMed ID: 27287359
[TBL] [Abstract][Full Text] [Related]
50. National cervical cancer prevention program in the Arab States: Strategies and cost-minimization study of the Tunisian case.
Gamaoun R
Vaccine; 2018 Aug; 36(33):5091-5096. PubMed ID: 29983258
[TBL] [Abstract][Full Text] [Related]
51. Cervical cancer: the Chilean perspective. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
Suarez E; Prieto M
Int J Gynaecol Obstet; 2006 Nov; 95 Suppl 1():S235-8. PubMed ID: 17161162
[No Abstract] [Full Text] [Related]
52. Factors influencing uptake of HPV vaccination among girls in Germany.
Schülein S; Taylor KJ; König J; Claus M; Blettner M; Klug SJ
BMC Public Health; 2016 Sep; 16():995. PubMed ID: 27645711
[TBL] [Abstract][Full Text] [Related]
53. [HPV vaccination and testing can improve cervix cancer screening].
Bistoletti P; Andersson S; Johansson BC
Lakartidningen; 2008 Jan 9-15; 105(1-2):56-7. PubMed ID: 18293750
[No Abstract] [Full Text] [Related]
54. Screening for gynecologic cancer.
Zanotti KM; Kennedy AW
Med Clin North Am; 1999 Nov; 83(6):1467-87. PubMed ID: 10584603
[TBL] [Abstract][Full Text] [Related]
55. Sociodemographic factors predicting mother's cervical screening and daughter's HPV vaccination uptake.
Spencer AM; Roberts SA; Brabin L; Patnick J; Verma A
J Epidemiol Community Health; 2014 Jun; 68(6):571-7. PubMed ID: 24567443
[TBL] [Abstract][Full Text] [Related]
56. Cervical cancer screening in the early post vaccine era.
Waxman AG
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
[TBL] [Abstract][Full Text] [Related]
57. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
58. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
59. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
[TBL] [Abstract][Full Text] [Related]
60. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.
Schiffman M
Cancer; 2007 Jun; 111(3):145-53. PubMed ID: 17487850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
